The effect of oral vs intravenous tranexamic acid in reducing blood loss after primary total hip arthroplasty: A randomized clinical trial
Thrombosis Research Feb 22, 2018
Cao G, et al. - Researchers ascertained if the administration of multiple boluses of oral and intravenous tranexamic acid (TXA) postoperatively was equivalent in reducing blood loss in primary total hip arthroplasty (THA). Without increasing the risk of thromboembolic diseases and wound complications, these multiple boluses were discovered to be equivalent in reducing blood loss, hemoglobin (Hb) and hematocrit (Hct) drop in primary THA.
Go to Original
Only Doctors with an M3 India account can read this article. Sign up for free or login with your existing account.
4 reasons why Doctors love M3 India
-
Exclusive Write-ups & Webinars by KOLs
-
Daily Quiz by specialty
-
Paid Market Research Surveys
-
Case discussions, News & Journals' summaries